Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Metastatic HER2-Negative Breast Cancer and Triple-Negative Breast Cancer (TNBC)
To see the complete question and investigator responses, move your mouse over the related topic.
Click the "Select Faculty Commentary" button to review full commentary (login required). View related video clips from our symposium at the 2011 ASCO Annual Meeting.
|
||||||
